| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.13 | 0.007 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.008 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.099 | 0.008 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.008 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.099 | 0.009 |